Statement of Changes in Beneficial Ownership (4)
March 05 2021 - 5:02PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
THOMAS H. LEE ADVISORS, LLC |
2. Issuer Name and Ticker or Trading Symbol
Syneos Health, Inc.
[
SYNH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
|
|
(Last)
(First)
(Middle)
C/O THOMAS H. LEE PARTNERS, L.P., 100 FEDERAL STREET, 35TH FLOOR |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/3/2021 |
|
(Street)
BOSTON, MA 02110
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Class A Common Stock | 3/3/2021 | | S | | 3717905 (4) | D | $74.175 | 9517640 (5) | I | See footnote (1)(2)(3) |
| Class A Common Stock | 3/3/2021 | | S | | 277114 (6) | D | $74.175 | 9106651 (7) | I | See footnote (1)(2)(3) |
| Class A Common Stock | 3/3/2021 | | S | | 631 (8) | D | $74.175 | 1535 (10) | D | |
| Class A Common Stock | 3/3/2021 | | S | | 242 (9) | D | $74.175 | 589 (11) | D | |
| Class A Common Stock | 3/3/2021 | | S | | 45 (12) | D | $74.175 | 1490 (14) | D | |
| Class A Common Stock | 3/3/2021 | | S | | 17 (13) | D | $74.175 | 572 (15) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Explanation of Responses: |
| (1) | See Exhibit 99.1 for text of footnote (1). |
| (2) | See Exhibit 99.1 for text of footnote (2). |
| (3) | See Exhibit 99.1 for text of footnote (3). |
| (4) | See Exhibit 99.1 for text of footnote (4). |
| (5) | See Exhibit 99.1 for text of footnote (5). |
| (6) | See Exhibit 99.1 for text of footnote (6). |
| (7) | See Exhibit 99.1 for text of footnote (7). |
| (8) | See Exhibit 99.1 for text of footnote (8). |
| (9) | See Exhibit 99.1 for text of footnote (9). |
| (10) | See Exhibit 99.1 for text of footnote (10). |
| (11) | See Exhibit 99.1 for text of footnote (11). |
| (12) | See Exhibit 99.1 for text of footnote (12). |
| (13) | See Exhibit 99.1 for text of footnote (13). |
| (14) | See Exhibit 99.1 for text of footnote (14). |
| (15) | See Exhibit 99.1 for text of footnote (15). |
Remarks:
Exhibit 99.1 (Form 4 Footnotes) and Exhibit 99.2 (Joint Filer Information) are incorporated herein by reference. This Form 4 is the first of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Thomas H. Lee Advisors, LLC. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
THOMAS H. LEE ADVISORS, LLC
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR
BOSTON, MA 02110 | X | X |
|
|
THL Fund VII Coinvestment Partners, L.P.
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR
BOSTON, MA 02110 | X | X |
|
|
THL Executive Fund VII, L.P.
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR
BOSTON, MA 02110 | X | X |
|
|
THL Equity Fund VII Investors (inVentiv), L.P.
C/O THOMAS H. LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR
BOSTON, MA 02110 | X | X |
|
|
Signatures
|
| ** See Exhibit 99.2 for Signatures | | 3/5/2021 |
| **Signature of Reporting Person | Date |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024
